The History of Psychedelics in Psychiatry

This book chapter (2020) in Pharmacopsychiatry provides an excellent overview of the history of psychedelics as they were used (and can be again) in psychiatry.

Abstract

Initial interest in the value of psychedelic drugs (“psychotomimetics”) in psychiatry began in the early 20th century, with explorations of the possibility that mescaline or peyote could produce psychosis-like effects. Over time, interest was focused on whether the effects of psychedelics could inform as to the underlying basis for psychiatric disorders. As research continued, and especially after the discovery of LSD in 1943, increasing interest in a role for psychedelics as adjuncts to psychotherapy began to evolve and became the major focus of work with psychedelics up to the present day.

Authors: David E. Nichols & Hannes Walter

Authors

Authors associated with this publication with profiles on Blossom

David E. Nichols
David E. Nichols is a researcher (specifically pharmacologist and medicinal chemist) at Purdue University (semi-retired in 2012). His psychedelics work has been ongoing since 1969.